
How The Craneware Group manages 340B compliance for home infusion
/ by Lisa Scholz, PharmD, MBA, FACHE, Senior Vice President Industry Relations
With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.